Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-23T12:43:11.715Z Has data issue: false hasContentIssue false
  • English
  • Français

The systemic absorption and disposition of levobupivacaine 0.5% after epidural administration in surgical patients: a stable-isotope study

Published online by Cambridge University Press:  23 December 2004

M. J. G. Simon ,
B. T. Veering ,
R. Stienstra ,
J. W. van Kleef ,
S. G. P. Williams ,
G. M. McGuire  and
A. G. L. Burm
M. J. G. Simon
Affiliation:
Leiden University Medical Centre, Department of Anaesthesiology, Leiden, The Netherlands
B. T. Veering
Affiliation:
Leiden University Medical Centre, Department of Anaesthesiology, Leiden, The Netherlands
R. Stienstra
Affiliation:
Leiden University Medical Centre, Department of Anaesthesiology, Leiden, The Netherlands
J. W. van Kleef
Affiliation:
Leiden University Medical Centre, Department of Anaesthesiology, Leiden, The Netherlands
S. G. P. Williams
Affiliation:
Inveresk Research International Ltd, Tranent, Scotland, UK
G. M. McGuire
Affiliation:
Inveresk Research International Ltd, Tranent, Scotland, UK
A. G. L. Burm
Affiliation:
Leiden University Medical Centre, Department of Anaesthesiology, Leiden, The Netherlands
Get access

Abstract

Summary

Background and objective: Absorption and disposition kinetics can be studied with a stable-isotope method. The aim of this study was to validate a stable-isotope method for levobupivacaine and to derive the relevant pharmacokinetics after epidural administration.

Methods: Eight volunteers (18–32 yr) received approximately 23 mg of both levobupivacaine and deuterium-labelled levobupivacaine simultaneously by intravenous infusion. Venous blood samples were taken for 8 h. Fifteen patients (23–85 yr) received 19 mL levobupivacaine 0.5% (including a 3 mL test dose) epidurally and, 25 min later, approximately 25 mg deuterium-labelled levobupivacaine (D3-levobupivacaine) intravenously. Arterial blood samples were collected for 24 h. Plasma concentrations were determined using liquid chromatography-mass spectrometry. Plasma concentration–time data were analysed by compartmental and non-compartmental analysis.

Results: Based on the ratio of the normalized areas under the curve of unlabelled and deuterium-labelled levobupivacaine in volunteers, as determined by both compartmental (mean ratio: 1.02, 90% CI: 1.00–1.04) and non-compartmental analysis (mean ratio: 1.02, 90% CI: 1.00–1.03) the two formulations were considered equivalent. In surgical patients the elimination half-life (mean ± SD: 196 ± 65 min), total body clearance (349 ± 114 mL min−1) and volume of distribution at steady state (56 ± 14 L), derived by compartmental analysis, were similar to those obtained by non-compartmental analysis. The absorption was bi-phasic. The fraction absorbed and half-life of the fast absorption process were 0.22 ± 0.06 and 5.2 ± 2.7 min, respectively. The values for the slow absorption process were 0.84 ± 0.14 and 386 ± 91 min, respectively.

Conclusions: D3-levobupivacaine is pharmacokinetically equivalent to unlabelled levobupivacaine and can be used to study the absorption and disposition kinetics after perineural administration of levobupivacaine in a single experiment.

Keywords

ANAESTHETIC TECHNIQUES, epiduralANAESTHETICS, LOCAL, levobupivacaineHUMAN EXPERIMENTATIONPHARMACOKINETICS, levobupivacaine
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 21 , Issue 6 , June 2004 , pp. 460 - 470
Copyright
2004 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Mather LE. Disposition of mepivacaine and bupivacaine enantiomers in sheep. Br J Anaesth 1991; 67: 239–246.Google Scholar
Mather LE, Rutten AJ, Plummer JL. Pharmacokinetics of bupivacaine enantiomers in sheep: influence of dosage regimen and study design. J Pharmacokinet Biopharm 1994; 22: 481–498.Google Scholar
Burm AGL, Van der Meer AD, Van Kleef JW, Zeijlmans PWM, Groen K. Pharmacokinetics of the enantiomers of bupivacaine following intravenous administration of the racemate. Br J Clin Pharmacol 1994; 38: 125–129.Google Scholar
Groen K, Mantel M, Zeijlmans PWM, et al. Pharmacokinetics of the enantiomers of bupivacaine and mepivacaine after epidural administration of the racemates. Anesth Analg 1998; 86: 361–366.Google Scholar
Lee-Son S, Wang GK, Concus A, Crill E, Strichartz G. Stereoselective inhibition of neuronal sodium channels by local anesthetics. Anesthesiology 1992; 77: 324–335.Google Scholar
Kanai Y, Katsuki H, Takasaki M. Comparisons of the anesthetic potency and intracellular concentrations of S(−) and R(+) bupivacaine and ropivacaine in crayfish giant axon in vitro. Anesth Analg 2000; 90: 415–420.Google Scholar
Vanhoutte F, Vereecke J, Verbeke N, Carmeliet E. Stereoselective effects of the enantiomers of bupivacaine on the electrophysiological properties of the guinea-pig papillary muscle. Br J Pharmacol 1991; 103: 1275–1281.Google Scholar
Denson DD, Behbehani MM, Gregg RV. Enantiomer-specific effects of an intravenously administered arrhythmogenic dose of bupivacaine on neurons of the nucleus tractus solitarius and the cardiovascular system in the anesthetized rat. Reg Anesth 1992; 17: 311–316.Google Scholar
Mazoit JX, Decaux A, Bouaziz H, Edouard A. Comparative ventricular electrophysiologic effect of racemic bupivacaine, levobupivacaine, and ropivacaine on the isolated rabbit heart. Anesthesiology 2000; 93: 784–792.Google Scholar
Thomas JM, Schug SA. Recent advances in the pharmacokinetics of local anaesthetics. Long-acting amide enantiomers and continuous infusions. Clin Pharmacokinet 1999; 36: 67–83.Google Scholar
Gennery B, Mather LE, Strichartz G. Levobupivacaine: new preclinical and clinical data. Semin Anesth 2000; 19: 132–148.Google Scholar
Burm AGL, Vermeulen NPE, Van Kleef JW, De Boer AG, Spierdijk J, Breimer DD. Pharmacokinetics of lignocaine and bupivacaine in surgical patients following epidural administration. Simultaneous investigation of absorption and disposition kinetics using stable isotopes. Clin Pharmacokinet 1987; 13: 191–203.Google Scholar
Burm AGL, De Boer AG, Van Kleef JW, et al. Pharmacokinetics of lidocaine and bupivacaine and stable isotope labelled analogues: a study in healthy volunteers. Biopharm Drug Dispos 1988; 9: 85–95.Google Scholar
Bader AM, Tsen LC, Camann WR, Nephew E, Datta S. Clinical effects and maternal and fetal plasma concentrations of 0.5% epidural levobupivacaine versus bupivacaine for cesarean delivery. Anesthesiology 1999; 90: 1596–1601.Google Scholar
Kopacz DJ, Allen HW, Thompson GE. A comparison of epidural levobupivacaine 0.75% with racemic bupivacaine for lower abdominal surgery. Anesth Analg 2000; 90: 642–648.Google Scholar
Riegelman S, Collier P. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J Pharmacokinet Biopharm 1980; 8: 509–534.Google Scholar
Benet LZ, Galeazzi RL. Noncompartmental determination of the steady-state volume of distribution. J Pharm Sci 1979; 68: 1071–1074.Google Scholar
Perrier D, Mayersohn M. Noncompartmental determination of the steady-state volume of distribution for any mode of administration. J Pharm Sci 1982; 71: 372–373.Google Scholar
Iga K, Ogawa Y, Yashiki T, Shimamoto T. Estimation of drug absorption rates using a deconvolution method with nonequal sampling times. J Pharmacokinet Biopharm 1986; 21: 213–225.Google Scholar
Veering BT, Burm AGL, Vletter AA, Van den Heuvel RPM, Onkenhout W, Spierdijk J. The effect of age on the systemic absorption, disposition and pharmacodynamics of bupivacaine after epidural administration. Clin Pharmacokinet 1992; 22: 75–84.Google Scholar
Pabst G, Jaeger H. Review of methods and criteria for the evaluation of bioequivalence studies. Eur J Clin Pharmacol 1990; 38: 5–10.Google Scholar
Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 1987; 15: 657–680.Google Scholar
McClellan KJ, Spencer CM. Levobupivacaine. Drugs 1998; 56: 355–362.Google Scholar
Gristwood RW, Greaves JL. Levobupivacaine: a new safer long acting local anaesthetic agent. Expert Opin Invest Drug 1999; 8: 861–876.Google Scholar
Tucker GT, Mather LE. Pharmacology of local anaesthetic agents. Pharmacokinetics of local anaesthetic agents. Br J Anaesth 1975; 47: 213–224.Google Scholar
Emanuelsson BM, Persson J, Alm C, Heller A, Gustafsson LL. Systemic absorption and block after epidural injection of ropivacaine in healthy volunteers. Anesthesiology 1997; 87: 1309–1317.Google Scholar
Aps C, Reynolds F. An intradermal study of the local anaesthetic and vascular effects of the isomers of bupivacaine. Br J Clin Pharmacol 1978; 6: 63–68.Google Scholar
Khodorova AB, Strichartz GR. The addition of dilute epinephrine produces equieffectiveness of bupivacaine enantiomers for cutaneous analgesia in the rat. Anesth Analg 2000; 91: 410–416.Google Scholar
Newton DJ, Burke D, Khan F, et al. Skin blood flow changes in response to intradermal injection of bupivacaine and levobupivacaine, assessed by laser Doppler imaging. Reg Anesth Pain Med 2000; 25: 626–631.Google Scholar
Bader AM, Tsen LC, Camann WR, Nephew E, Datta S. Clinical effects and maternal and fetal plasma concentrations of 0.5% epidural levobupivacaine versus bupivacaine for cesarean delivery. Anesthesiology 1999; 90: 1596–1601.Google Scholar
Cox CR, Faccenda KA, Gilhooly C, Bannister J, Scott NB, Morrison LM. Extradural S(−)-bupivacaine: comparison with racemic RS-bupivacaine. Br J Anaesth 1998; 80: 289–293.Google Scholar